{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15973768", "DateCompleted": {"Year": "2005", "Month": "11", "Day": "29"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1673-1581", "JournalIssue": {"Volume": "6", "Issue": "7", "PubDate": {"Year": "2005", "Month": "Jul"}}, "Title": "Journal of Zhejiang University. Science. B", "ISOAbbreviation": "J Zhejiang Univ Sci B"}, "ArticleTitle": "Screening the active constituents of Chinese medicinal herbs as potent inhibitors of Cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2 kinase.", "Pagination": {"StartPage": "656", "EndPage": "663", "MedlinePgn": "656-63"}, "Abstract": {"AbstractText": ["To screen and evaluate the active constituents of Chinese medicinal herbs as potent inhibitors of Cdc25 phosphatase.", "The affinity chromatography purified glutashione-S-transferase/Cdc25A phosphatase fusion protein and Cdc2/cyclin B from the extracts of starfish M phase oocytes are used as the cell cycle-specific targets for screening the antimitotic constituents. We tested 9 extracts isolated from the Chinese medicinal herbs and vegetables including the agents currently used in cancer treatment by measuring the inhibition of Cdc25A phosphatase and Cdc2 kinase activity. The antitumor activity of the extracts was also evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and flow cytometry.", "Cdc25A inhibitory activity and antitumor activity are detected in the extracts isolated from three Chinese medicinal herbs Agrimona pilosa; Herba solani lyrati; Galla chinesis.", "We found three extracts isolated from Chinese medicinal herbs have potential inhibitory activity of Cdc25 phosphatase using a highly specific mechanism-based screen assay for antimitotic drug discovery."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Institute, Zhejiang University, Hangzhou, China. YangH@moffitt.usf.edu"}], "Identifier": [], "LastName": "Yang", "ForeName": "Hua", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zheng", "ForeName": "Shu", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Meijer", "ForeName": "Laurent", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Shi-min", "Initials": "SM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Leclerc", "ForeName": "Sophie", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yu", "ForeName": "Lin-lin", "Initials": "LL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cheng", "ForeName": "Jin-quan", "Initials": "JQ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Su-zhan", "Initials": "SZ"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "J Zhejiang Univ Sci B", "NlmUniqueID": "101236535", "ISSNLinking": "1673-1581"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cell Cycle Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "Cyclin-Dependent Kinases"}, {"RegistryNumber": "EC 3.1.3.48", "NameOfSubstance": "CDC25B protein, human"}, {"RegistryNumber": "EC 3.1.3.48", "NameOfSubstance": "cdc25 Phosphatases"}, {"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "Cyclin-Dependent Kinase-Activating Kinase"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Cell Cycle Proteins"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclin-Dependent Kinases"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["analysis", "chemistry", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lethal Dose 50"}, {"QualifierName": ["drug therapy", "enzymology", "pathology"], "DescriptorName": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive"}, {"QualifierName": ["methods"], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mitosis"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "cdc25 Phosphatases"}, {"QualifierName": [], "DescriptorName": "Cyclin-Dependent Kinase-Activating Kinase"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Baratte B, Meijer L, Galaktionov K, Beach D. Screening for antimitotic compounds using the Cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2/cyclin Bcdc13 protein kinase. Anticancer Res. 1992;12:873\u2013880.", "ArticleIdList": ["1320360"]}, {"Citation": "Cangi MG, Cukor B, Soung P, Signoretti S, Moreira J, Ranashinge GM, Cady B, Pagano M, Loda M. Role of Cdc25A phosphatase in human breast cancer. J Clin Invest. 2000;106:753\u2013761.", "ArticleIdList": ["PMC381390", "10995786"]}, {"Citation": "Choudhary B. The new international seed treaty: Promises and prospects for food security. Current Science. 2002;83:366\u2013369."}, {"Citation": "Constantinou A, Stoner GD, Mehta R, Rao K, Runyan C, Moon R. The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro. Nutr Cancer. 1995;23:121\u2013130.", "ArticleIdList": ["7644381"]}, {"Citation": "Farnsworth NR, Loub WD. The Potentials for Extracting Protein, Medicines, and Other Useful Chemicals. Workshop Proceedings, OTA-BP-F-23. Washington, D.C.: US Congress, Office of Technology Assessment; 1983. Information Gathering and Data Hases that are Pertinent to the Development of Plant-derived Drugs; pp. 178\u2013195."}, {"Citation": "Farnsworth NR, Soejarto DD. Potential consequences of plant extinction in the United States on the current and future availability of prescription drugs. Econ Bot. 1985;39:231\u2013240."}, {"Citation": "Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull WHO. 1985;63(6):965\u2013981.", "ArticleIdList": ["PMC2536466", "3879679"]}, {"Citation": "Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M, Beach D. Cdc25 phosphatases as potential human oncogenes. Science (Wash DC) 1995;269:1575\u20131577.", "ArticleIdList": ["7667636"]}, {"Citation": "Galaktionov K, Chen X, Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (Lond) 1996;382:511\u2013517.", "ArticleIdList": ["8700224"]}, {"Citation": "Ham SW, Park J, Lee SJ, Kim W, Kang K, Choi KH. Naphthoquinone analogs as inactivators of Cdc25 phosphatase. Bioorg Med Chem Lett. 1998;8:2507\u20132510.", "ArticleIdList": ["9873570"]}, {"Citation": "Hernandez S, Bessa X, Bea S, Hernandez L, Nadal A, Mallofre C, Muntane J, Castells A, Fernandez PL, Cardesa A. Differential expression of Cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma. Lab Invest. 2001;81:465\u2013473.", "ArticleIdList": ["11304565"]}, {"Citation": "Hoffman I, Draetta I, Karsenti G. Activation of the phosphatase activity of human Cdc25A by a CDK2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 1994;13:4302\u20134310.", "ArticleIdList": ["PMC395357", "7523110"]}, {"Citation": "Hotz MA, Gong J, Traganos F, Darzynkiewicz Z. Flow cytometric detection of apoptosis: Comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry. 1994;5:237\u2013241.", "ArticleIdList": ["8187583"]}, {"Citation": "Jinno S, Suto J, Nagata A, Igarashi M, Kanaoka Y, Nojima H, Okayama H. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 1994;13:1549\u20131556.", "ArticleIdList": ["PMC394984", "8156993"]}, {"Citation": "Kim HJ, Kang SK, Mun JY, Chun YJ, Choi KH, Kim MY. Involvement of Akt in mitochondria-dependent apoptosis induced by a Cdc25 phosphatase inhibitor naphthoquinone analog. FEBS Lett. 2003;555:217\u2013222.", "ArticleIdList": ["14644418"]}, {"Citation": "Lazo JS, Aslan DC, Southwick EC, Cooley KA, Ducruet AP, Joo B, Vogt A, Wipf P. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. J Med Chem. 2001;44:4042\u20134049.", "ArticleIdList": ["11708908"]}, {"Citation": "Lazo JS, Nemoto K, Pestell KE. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors. Mol Pharmacol. 2002;61:720\u2013728.", "ArticleIdList": ["11901209"]}, {"Citation": "Losso JN, Bansode RR, Trappey A, Bawadi HA, Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem. 2004;15:672\u2013678.", "ArticleIdList": ["15590271"]}, {"Citation": "Loukaci A, Le Saout I, Samadi M, Leclerc S, Damiens E, Meijer L, Debitus C, Guyot M. Coscinosulfate, a Cdc25 phosphatase inhibitor from the sponge coscinoderma mathewsi. Bioorg Med Chem. 2001;9:3049\u20133054.", "ArticleIdList": ["11597488"]}, {"Citation": "Lyon MA, Ducruet AP, Wipf P, Lazo JS. Dual-specificity phosphatases as targets for antineoplastic agents. Nat Rev Drug Discov. 2002;1:961\u2013976.", "ArticleIdList": ["12461518"]}, {"Citation": "Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, Lukas J. Rapid destruction of human Cdc25A in response to DNA damage. Science (Wash DC) 2000;288:1425\u20131429.", "ArticleIdList": ["10827953"]}, {"Citation": "Mertens-Talcott SU, Percival SS. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett. 2005;218:141\u2013151.", "ArticleIdList": ["15670891"]}, {"Citation": "Millar JB, Blevitt J, Gerace L, Sadhu K, Featherstone C, Russell P. p55Cdc25 is a nuclear protein required for the initiation of mitosis in human cells. Proc Natl Acad Sci USA. 1991;88:10500\u201310504.", "ArticleIdList": ["PMC52956", "1961714"]}, {"Citation": "Molinari M, Mercurio C, Dominguez J, Goubin F, Draetta GF. Human Cdc25A inactivation is response to S phase inhibition and its role in preventing premature mitosis. EMBO J. 2000;1:71\u201379.", "ArticleIdList": ["PMC1083693", "11256629"]}, {"Citation": "Mukherjee PK. GMP for Indian Systems of Medicine. In: Mukherjee PK, Verpoorte R, editors. GMP for Botanicals: Regulatory and Quality Issues on Phytomedicines. New Delhi: Business Horizons; 2003. pp. 99\u2013112."}, {"Citation": "Nagata A, Igarashi M, Jinno S, Suto K, Okayama H. An additional homolog of the fission yeast Cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biologist. 1991;3:959\u2013968.", "ArticleIdList": ["1662986"]}, {"Citation": "Nilsson I, Hoffman I. Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res. 2000;4:107\u2013114.", "ArticleIdList": ["10740819"]}, {"Citation": "Prevost GP, Brezak MC, Goubin F, Mondesert O, Galcera MO, Quaranta M, Alb YF, Lavergne O, Ducommun B. Inhibitors of the Cdc25 phosphatases. Prog Cell Cycle Res. 2003;5:225\u2013234.", "ArticleIdList": ["14593717"]}, {"Citation": "Pu L, Amoscato AA, Bier ME, Lazo JS. Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 7-chloro-6-(2-morpholin-4-ylethylamino)-quinoline-5,8-dione. J Biol Chem. 2002;277:46877\u201346885.", "ArticleIdList": ["12356752"]}, {"Citation": "Ramakrishnappa K. Biodiversity and the Ecosystem Approach in Agriculture, Forestry and Fisheries. New York, USA: 2003. Impact of Cultivation and Gathering of Medicinal Plants on Biodiversity: Case Studies from India; pp. 210\u2013215. United Nations Publications."}, {"Citation": "Sadhu KS, Reed I, Richardso NH, Russell P. Human homolog of fission yeast Cdc25 mitotic inducer is predominantly expressed in G2 . Proc Natl Acad Sci USA. 1990;87:5139\u20135143.", "ArticleIdList": ["PMC54277", "2195549"]}, {"Citation": "Sohn J, Kiburz B, Li Z, Deng L, Safi A, Pirrung MC, Rudolph J. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones. J Med Chem. 2003;46:2580\u20132588.", "ArticleIdList": ["12801222"]}, {"Citation": "Tamura K, Southwick EC, Kerns J, Rosi K, Carr BI, Wilcox C, Lazo JS. Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue. Cancer Res. 2000;60:1317\u20131325.", "ArticleIdList": ["10728693"]}, {"Citation": "Twentyman PR, Fox NE, Rees JK. Chemosensitivity testing of fresh leukemia cells using the MTT colorimetric assay. Br J Haematol. 1989;71:19\u201322.", "ArticleIdList": ["2917126"]}, {"Citation": "Wakdikar S. Global health care challenge: Indian experiences and new prescriptions. Electronic J of Biotechnology. 2004;7:214\u2013220."}, {"Citation": "Yang H, Wang XP, Yu LL, Zheng S. The antitumor activity of elemene is associated with apoptosis. Zhonghua Zhong Liu Za Zhi. 1996;18:169\u2013172. (in Chinese)", "ArticleIdList": ["9387246"]}, {"Citation": "Zheng S, Yang H, Zhang S, Wang X, Yu L, Lu J, Li J. Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention. J Cell Biochem. 1997;27(Suppl):106\u2013112.", "ArticleIdList": ["9591200"]}]}], "History": [{"Year": "2005", "Month": "6", "Day": "24", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "12", "Day": "13", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "6", "Day": "24", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15973768", "PMC1389800", "10.1631/jzus.2005.B0656"]}}], "PubmedBookArticle": []}